ISSN: 1078-1552

Journal Home

Journal Guideline

Journal of Oncology Pharmacy Practice Q3 Unclaimed

SAGE Publications Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Oncology Pharmacy Practice is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 41. It has an SJR impact factor of 0,467 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,467.

Journal of Oncology Pharmacy Practice focuses its scope in these topics and keywords: patients, cell, pharmacistmanaged, leukemiadoes, metastatic, mrcc, myelogenous, officebased, oncologists, oncology, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q3) Oncology (Q3) Pharmacology (medical) (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,467

SJR Impact factor

41

H Index

400

Total Docs (Last Year)

949

Total Docs (3 years)

10218

Total Refs

1423

Total Cites (3 years)

869

Citable Docs (3 years)

1.44

Cites/Doc (2 years)

25.55

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Virus Genes Q3
Advances in dental research Q3
Biotechnology Letters Q3
Annali dell'Istituto Superiore di Sanita Q3
Frontiers of neurology and neuroscience Q3

Compare this journals

Aims and Scope

Best articles by citations

Effects of the leucovorin shortage: Pilot study investigating cost, efficacy, and toxicity comparison of low fixed-dose versus body surface area-adjusted leucovorin dosing in patients with resectable colon or metastatic colorectal cancer

Busulfan dosing (Q6 or Q24) with adjusted or actual body weight, does it matter?

A controlled before and after study to evaluate a patient and health professional partnership model towards effective medication reconciliation

Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response

Fatal pulmonary toxicity due to carfilzomib (Kyprolis‚Ñ¢)

Physical exercise for cytotoxic drug-induced fatigue

Rifampin-sirolimus-voriconazole interaction in a hematopoietic cell transplant recipient

The use of sodium hyaluronate for the treatment of radiation recall dermatitis

Compatibility and stability of the novel anti-cancer agent C1311 in infusion devices and its in vitro biocompatibility

Capecitabine: a novel, orally administered, tumour-activated treatment for breast cancer

Hyperammonemia secondary to asparaginase: A case series

Proteinuria with first-line therapy of metastatic renal cell cancer

SHOW MORE ARTICLES

A case report of three patients with metastatic gastric cancer on hemodialysis who were treated with cisplatin-fluorouracil regimen

Proposal of a simple and rapid method for the chemotherapy preparations analytical control by spectrophotometry UV-Vis method

Comparing venous thromboembolism prophylactic strategies for ambulatory multiple myeloma patients on immunomodulatory drug therapy

Pyoderma gangrenosum due to lenalidomide use for multiple myeloma

Detection of 5-fluorouracil surface contamination in near real time

Pegfilgrastim use and bone pain: a cohort study of community-based cancer patients

Atypical presentation of fever as hypersensitivity reaction to oxaliplatin

Single 6-mg dose of rasburicase: The experience in a large academic medical center

Role of dimethylsulfoxide for management of chemotherapy extravasation

Letter to the editor

A review of imatinib mesilate in the treatment of patients with gastrointestinal stromal tumours and chronic myeloid leukaemia

Effects of gender on capecitabine toxicity in colorectal cancer